NETs induced by tumor-derived CXCL8 coupled with CXCR2 promoted diffuse large B-cell lymphoma (DLBCL) progression by activating Toll-like receptor 9 (TLR9), an important DNA sensor, and its downstream pathways. Here, TLR9 is linked to neoplasm.